NWT Uranium (OTCMKTS:CPTRF) & Sharps Technology (NASDAQ:STSS) Critical Analysis

NWT Uranium (OTCMKTS:CPTRF) and Sharps Technology (NASDAQ:STSS) are both medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their analyst recommendations, valuation, earnings, profitability, dividends, risk and institutional ownership.

Institutional and Insider Ownership

17.2% of Sharps Technology shares are owned by institutional investors. 1.2% of Sharps Technology shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Profitability

This table compares NWT Uranium and Sharps Technology’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
NWT Uranium	N/A	-85.62%	-77.66%
Sharps Technology	N/A	-8.72%	-5.30%

Valuation and Earnings

This table compares NWT Uranium and Sharps Technology”s gross revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
NWT Uranium	$27.25 million	N/A	$6.69 million	$4.08	0.04
Sharps Technology	N/A	N/A	-$9.30 million	($1,212.34)	0.00

NWT Uranium has higher revenue and earnings than Sharps Technology. Sharps Technology is trading at a lower price-to-earnings ratio than NWT Uranium, indicating that it is currently the more affordable of the two stocks.

Analyst Ratings

This is a breakdown of recent ratings and target prices for NWT Uranium and Sharps Technology, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
NWT Uranium	0	0	0	0	0.00
Sharps Technology	1	0	0	0	1.00

Summary

Sharps Technology beats NWT Uranium on 6 of the 9 factors compared between the two stocks.

About NWT Uranium

Captor Capital Corp. engages in the manufacture and retail sale of cannabis products in the United States. It operates two dispensaries under the CHAI Cannabis Co. brand in Santa Cruz and Monterey, California, as well as operates an e-commerce site under the CHAI-brand. The company was formerly known as NWT Uranium Corp. and changed its name to Captor Capital Corp. in June 2017. Captor Capital Corp. was incorporated in 2003 and is based in Toronto, Canada.

About Sharps Technology

Sharps Technology, Inc., a medical device company, researches, designs, develops, manufactures, distributes, and sells safety syringe products in the United States. It offers Sharps Provensa, an ultra-low waste space syringe for the administration of various vaccines and injectable medications. Sharps Technology, Inc. was incorporated in 2017 and is based in Melville, New York.